TESTING PANELS

 

Pan-Cancer Panel (114 genes)

The Pan Cancer Panel is a comprehensive next-generation sequencing (NGS) panel that analyzes genes associated with risks for hereditary breast, colon, gastric, uterine, ovarian, brain, nervous system, renal, urinary tract, prostate, and pancreatic cancers.


Common/High Risk Cancer Panel (32 genes)

The Common/High-Risk Cancer Panel is a comprehensive next-generation sequencing (NGS) panel that analyzes genes associated with increased risks for hereditary breast, colon, uterine, ovarian, and pancreatic cancers.


Breast Cancer Panel (27 genes)

The Breast Cancer Panel is a comprehensive next-generation sequencing (NGS) panel that analyzes genes associated with increased risks for hereditary breast cancer.


Colorectal Cancer Panel (25 genes)

The Colorectal Cancer Panel is a comprehensive next-generation sequencing (NGS) panel that analyzes genes associated with increased risks for hereditary colorectal cancer.


Ovarian/Uterine Cancer Panel (18 genes)

The Ovarian/Uterine Cancer Panel is a comprehensive next-generation sequencing (NGS) panel that analyzes genes associated with increased risks for hereditary ovarian and uterine cancer.


Pancreatic Cancer Panel (28 genes)

The Pancreatic Cancer Panel is a comprehensive next-generation sequencing (NGS) panel that analyzes genes associated with increased risks for hereditary pancreatic cancer.


Thyroid Cancer Panel (11 genes)

The Thyroid Cancer Panel is a comprehensive next-generation sequencing (NGS) panel that analyzes genes associated with increased risks for hereditary thyroid cancer.


Brain and Nervous System Cancer Panel (42 genes)

The Brain and Nervous System Cancer Panel is a comprehensive next-generation sequencing (NGS) panel that analyzes genes associated with increased risks for hereditary brain and nervous system cancer.


Renal Cancer Panel (30 genes)

The Renal/Urinary Tract Cancer Panel is a comprehensive next-generation sequencing (NGS) panel that analyzes genes associated with increased risks for hereditary renal cancer.